JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Quantitative drug safety and benefit risk evaluation

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Quantitative drug safety and benefit risk evaluation

Quantitative drug safety and benefit risk evaluation

Veiledende pris

kr 1 033,00

Produseres på bestilling

ISBN/Varenr

9781032191119

Omtale

This book provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.

Vis hele omtalen… Vis mindre

Produktinformasjon

ISBN/Varenr: 9781032191119
Utgivelsesdato: 29.01.2024
Utgivelsesår: 2024
Forlag: Taylor and Francis
Innbinding: Heftet
Serie: Chapman & Hall/CRC Biostatistics Series
Språk: Engelsk
Aldersgrense: 0
Opplag: 0
Utgave: 0
Illustrert: Nei
Sider: 382